Clinical Trials Directory

Trials / Completed

CompletedNCT03092531

Positive Steps to Enhance Problem Solving Skills

Adaptive Intervention Strategies Trial for Strengthening Adherence to Antiretroviral HIV Treatment Among Youth

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
16 Years – 29 Years
Healthy volunteers
Accepted

Summary

This randomized control trial is to test the efficacy of a stepped-care "adaptive" Antiretroviral Therapy (ART) adherence intervention ("Positive STEPS") for HIV infected adolescents and young adults, ages 16 to 29. Stepped care is a healthcare delivery model in which the least resource intensive part of an intervention is delivered first, and only those who do not improve then receive the high intensity, more resource intensive part of an intervention.

Detailed description

HIV infected adolescents and young adults will be recruited from Providence, Rhode Island, Boston, Massachusetts and Chicago, Illinois. Participants will be equally randomized to: 1. "Positive STEPS" - a stepped care, adherence intervention with integrated technology (2-way daily text messaging aimed at improving ART adherence). If text messaging is not sufficient to overcome the barriers to ART adherence;these individuals will then also receive the more intensive component based on general principles of cognitive-behavioral therapy. 2. Standard of Care comparison group including a brief adherence educational session. This will consist of a review of medications and recommended dosing (i.e., to understand regimen), adherence expectations, toxicity expectations and medication misperceptions.The participant will then view a 20-minute animated tutorial which explains the importance of adherence to antiretroviral medication effectiveness.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPositive STEPSStep 1: 2 way SMS text messages; Step 2: Five in-person, counseling sessions. Each counseling session will last approximately 50 minutes.

Timeline

Start date
2018-02-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2017-03-28
Last updated
2024-07-25

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03092531. Inclusion in this directory is not an endorsement.